Medication Utilization and Lung Function Changes after Initiation of
Treatment with Elexacaftor/Tezacaftor/Ivacaftor
- Richard De Vuyst,
- Charissa Kam
, - Cameron McKinzie
, - Charles Esther
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Charissa Kam
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
The University of North Carolina at Chapel Hill
Author ProfileCameron McKinzie
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
The University of North Carolina at Chapel Hill
Author ProfileCharles Esther
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
The University of North Carolina at Chapel Hill
Author ProfileSubmitted to Pediatric Pulmonology 18 Feb 2024Review(s) Completed, Editorial Evaluation Pending
20 Feb 2024Editorial Decision: Revise Major
18 Mar 2024Submission Checks Completed
18 Mar 2024Assigned to Editor
18 Mar 2024Review(s) Completed, Editorial Evaluation Pending
18 Mar 2024Reviewer(s) Assigned
07 Apr 2024Editorial Decision: Accept